Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

PsyBio Therapeutics Corp V.PSYB.H

Alternate Symbol(s):  PSYBF

PsyBio Therapeutics Corp. is a Canada-based biotechnology company. The Company is focused on discovering, designing and developing psycho-focused therapeutics to improve mental and neurological conditions. It is focused on understanding the value of tryptamines and other related psycho-targeted molecules as therapeutic candidates to improve mental and neurological health. The Company is engaged in research and development for occurring psychoactive tryptamines, which is originally discovered in different varieties of hallucinogenic mushrooms, other tryptamines and phenethylamines, and combinations thereof. The Company utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.


TSXV:PSYB.H - Post by User

Post by partystockeron Dec 15, 2021 11:55am
191 Views
Post# 34233057

$ORIG worth keeping an eye on

$ORIG worth keeping an eye on

With public acceptance of therapeutic psychedelics increasing, there are a few companies on my radar to watch in the immediate future. With business publications starting to hop on the trend now, it’s only a matter of time before we start to see an uptick in the psychedelics market overall.


One of the Canadian players I’m keeping an eye on right now is psychedelic fund Origin Therapeutics. Origin Therapeutics is expected to IPO before the end of the quarter under the ticker $ORIG. 


Origin announced their official leadership team earlier this month, and it looks like they’ve assembled a strong group. I’m excited to see how $ORIG will perform, as I think they offer a unique portfolio that offers some great exposure to private companies in the psychedelics field.


With $ORIG’s recently IPO’d investee TripSitter positioned to potentially see a swing in prices, it’s a great time to keep an eye on the company right now.



https://www.bcbusiness.ca/BCs-functional-and-psychedelic-mushroom-industry-is-having-a-shroom-boom
<< Previous
Bullboard Posts
Next >>